Testosterone deficiency syndrome and prostate cancer: illustrative annotations for a debate

Auteurs-es

  • Alvaro Morales Centre for Applied Urological Research and the Department of Urology, Queen’s University and General Hospital, Kingston, ON
  • Angela Black Centre for Applied Urological Research and the Department of Urology, Queen’s University and General Hospital, Kingston, ON

DOI :

https://doi.org/10.5489/cuaj.528

Résumé

As illustrated in this issue of the CUAJ,1 the use of testosterone
in elderly men diagnosed with testosterone deficiency syndrome
(TDS), or hypogonadism, remains controversial. Perhaps the most
contentious point refers to the effect of supplemental testosterone on
prostate health. In the last few years, small studies appear to indicate
that in men treated successfully for prostate cancer and TDS, testosterone
treatment is warranted, usually successful and largely free of serious
adverse effects.2,3 To complement some of the points raised, we present
a case that typifies the situation and strengthens some of the opinions
expressed in the Point / Counterpoint section of this issue.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Bibliographies de l'auteur-e

Alvaro Morales, Centre for Applied Urological Research and the Department of Urology, Queen’s University and General Hospital, Kingston, ON

Angela Black, Centre for Applied Urological Research and the Department of Urology, Queen’s University and General Hospital, Kingston, ON

Téléchargements

Comment citer

Morales, A., & Black, A. (2013). Testosterone deficiency syndrome and prostate cancer: illustrative annotations for a debate. Canadian Urological Association Journal, 2(1), 52–4. https://doi.org/10.5489/cuaj.528

Numéro

Rubrique

Case Report